Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

[video]The Government Shutdown Won't Stop This FDA Meeting
Motley Fool
Monday, October 7, 2013 - 8:46am
tags:
FDA, Amarin, Vascepa
Will This Company Face the Same Restructuring as Merck?
Motley Fool
Monday, October 7, 2013 - 8:45am
tags:
Merck, layoffs, Eli Lilly, restructuring
Teva announces Copaxone patent win
Seeking Alpha
Sunday, October 6, 2013 - 9:22am
tags:
Teva, Copaxone, patents
This Company Is Focused on Delivering Value to Patients and Shareholders
Motley Fool
Sunday, October 6, 2013 - 9:19am
tags:
Dyax, DX-2930, angioedema
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sunday, October 6, 2013 - 9:18am
tags:
Achillion, Arena Pharmaceuticals, Lannett
What's Behind This Biotech's 40% Pop?
Motley Fool
Sunday, October 6, 2013 - 9:16am
tags:
Discovery Labs
'Obamacare' boost to Indian pharmaceutical industry
BBC, UK
Saturday, October 5, 2013 - 10:30am
tags:
Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases - Angel Broking
Equity Bulls
Saturday, October 5, 2013 - 10:26am
tags:
Sun Pharma, Intrexon, wet age-related macular degeneration, age-related macular degeneration, macular, edema, uveitis, diabetic retinopathy
Takeda Highlights Data from Clinical Trial of Investigational Norovirus Vaccine Candidate
Pipeline Review
Saturday, October 5, 2013 - 10:23am
tags:
Takeda, norovirus, vaccines
FDA Approves New Hot Flash Treatment for Menopause
Investor Place
Saturday, October 5, 2013 - 10:19am
tags:
Duavee, menopause, Pfizer, Ligand Pharmaceuticals
Biotech Buyout Celebration or Raw Deal?
Motley Fool
Saturday, October 5, 2013 - 9:55am
tags:
Astex, Otsuka, M&A
Are $300K Drugs Disruptive To The Healthcare System?
Forbes
Saturday, October 5, 2013 - 9:53am
tags:
Is This Biotech Cornering the Market for MS Treatments?
Motley Fool
Saturday, October 5, 2013 - 9:52am
tags:
Biogen Idec, MS, multiple sclerosis
Should Drugmakers Pay Punitive Damages? Novartis Says No Comment Now Follow Comments
Forbes
Saturday, October 5, 2013 - 9:51am
tags:
Novartis, lawsuits
2 Companies Suffering From Generic Competition and 1 That's Set to Benefit
Motley Fool
Saturday, October 5, 2013 - 9:50am
tags:
Novartis, generics, GSK, Ranbaxy
GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Yahoo/Globe Newswire
Saturday, October 5, 2013 - 9:31am
tags:
ofatumumab, GSK, Genmab, Arzerra, leukemia, chronic lymphocytic leukemia
Arena's Belviq Sales Pass 4,000 On IMS
Seeking Alpha
Saturday, October 5, 2013 - 9:29am
tags:
Arena, Belviq, obesity, weight loss
Discovery Laboratories: What The Marketing Approval Of Surfaxin Could Mean To The Stock
Seeking Alpha
Saturday, October 5, 2013 - 9:27am
tags:
Surfaxin, Discovery Labs
Why VIVUS Is Poised to Bounce Back
Motley Fool
Saturday, October 5, 2013 - 9:26am
tags:
Vivus
Good News for Valeant
Yahoo/Zacks
Saturday, October 5, 2013 - 9:20am
tags:
Valeant Pharmaceuticals, contact lenses

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.